VETIGEL

About Cresilon

Cresilon is a commercial-stage medical device company addressing the critical global challenge of uncontrolled bleeding through its innovative, plant-based hydrogel technology. Its flagship products, TRAUMAGEL (FDA-cleared for human trauma) and VETIGEL (for veterinary use), are designed to achieve rapid hemostasis across diverse wound geometries. The company has gained significant recognition, including being named the #1 most innovative company in medical devices by Fast Company in 2026, and is focused on expanding the adoption of its life-saving technology across pre-hospital, hospital, and veterinary care settings.

About Zomedica Pharmaceuticals

Zomedica is a veterinary health company focused on enhancing diagnostic and therapeutic care for companion animals. The company has successfully pivoted from a therapeutic focus to become a commercial-stage entity with a diversified portfolio, anchored by its TRUFORMA® diagnostic platform and augmented by strategic acquisitions in shockwave therapy, hemostatic gels, and targeted PEMF devices. Its strategy is to drive growth by expanding its diagnostic assay menu, integrating its multi-brand commercial portfolio, and leveraging its direct sales force to capture a greater share of the in-clinic veterinary market.

Therapeutic Areas